Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
2
50%
Ph phase_4
1
25%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)

Trials by Status

completed250%
not_yet_recruiting125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

A Study of TCD601 in de Novo Renal Transplant Recipients

NCT05669001
not_yet_recruitingphase_3

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

NCT05326087
completedphase_4

Belatacept 3 Month Post Transplant Conversion Study

NCT02213068
terminatedphase_3

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

NCT02449161

Clinical Trials (4)

Showing 4 of 4 trials
NCT05669001Phase 2

A Study of TCD601 in de Novo Renal Transplant Recipients

Completed
NCT05326087Phase 3

Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

Not Yet Recruiting
NCT02213068Phase 4

Belatacept 3 Month Post Transplant Conversion Study

Completed
NCT02449161Phase 3

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4